In stromal fibroblasts, miR-20a (ranked second in the WINMDA forecast list) can modulate chemokine C–X–C ligand 8 (CXCL8) function, thereby influencing tumor latency [42]. The gene discussed is CXCL8; the disease is neoplasm.